Surges After News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Ocuphire Pharma, Inc (NASDAQ: OCUP) Surges After VEGA-1 Phase 2 Trial Met Study Endpoints In Presbyopic Patients” Ocuphire Pharma, Inc. (NASDAQ: OCUP) surged over 40% in premarket trading after the company’s VEGA-1 Phase 2 Trial in Presbyopia Met its Primary and Secondary Endpoints. Key secondary endpoints on visual acuity and pupil diameter showed statistical significance and the Company now plans to advance into Phase 3 registration trials. Ocuphire is a publicly traded (NASDAQ: OCUP), clinical-stage o...

by Tyler Durden Friday, Apr 23, 2021 - 08:03 AM US equity futures rebounded Friday following Thursday's 1% selloff as investors digested a proposal for higher capital gains taxes and realized that i) it is nothing new compared to previous media reports and ii) the most likely outcome is a compromise tax rate (Goldman expects a final number no higher than 28%).  Still, both the S&P 500 and Dow are on course for weekly declines, after four straight weeks of gains. At 730 a.m. ET, Dow e-minis were up 38 points, or 0.11%, S&P 500 e-minis were up 9 points, or 0.22%, and Nasdaq 100 e-minis were up...